Search for biomarkers for ketamine response from changes of cytokines in the patients with treatment resistant depression

被引:0
|
作者
Su, Tung-Ping [1 ,2 ,3 ,4 ]
Chen, Mu-Hong [2 ,3 ]
Li, Cheng-Da [1 ,2 ,3 ]
Bai, Ya-Mei [1 ,2 ,3 ]
Chang, Annie [2 ]
Wu, Hui-Ju [2 ]
Lin, Wei-Chen [2 ,3 ]
Tu, Pei-Chi [2 ,4 ,5 ]
机构
[1] Natl Yang Ming Univ, Dept Psychiat, Taipei 112, Taiwan
[2] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan
[3] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan
[4] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan
[5] Inst Philosophy Mind & Cognit, Taipei, Taiwan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PS103
引用
收藏
页码:82 / 83
页数:2
相关论文
共 50 条
  • [21] Gene Expression and Ketamine Response in Subjects With Treatment-Resistant Depression
    Mohazzab-Hosseinian, Sahra
    Kadriu, Bashkim
    Zandi, Peter
    Zarate, Carlos
    Goes, Fernando
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 318 - 319
  • [22] Exploring Ketamine Use in Geriatric Patients Suffering From Treatment-Resistant Depression
    Janjua, A. U.
    Glass, Oliver M.
    Janjua, Nabeel A.
    Hermida, Adriana P.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 26 (03): : S88 - S89
  • [23] Hormones, cytokines, and adipokines in the course of depression - potential biomarkers for treatment response?
    Kloiber, S.
    Hennings, J.
    Uhr, M.
    Lucae, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 187 - 187
  • [24] Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation
    Gilbert, Jessica R.
    Zarate, Carlos A., Jr.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2020, 189
  • [25] The cortisol awakening response in treatment-resistant depression is not a biomarker of the clinical response to ketamine
    Naughton, M.
    Allen, A. P.
    Clarke, G.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    Cryan, J. F.
    Dinan, T. G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S401 - S401
  • [26] Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
    Kwasny, Aleksander
    Cubala, Wieslaw Jerzy
    Wlodarczyk, Adam
    Pastuszak, Krzysztof
    PHARMACOLOGICAL REPORTS, 2024, 76 (06) : 1325 - 1332
  • [27] Neural Correlates of Treatment Response to Intravenous Ketamine in Adolescents With Treatment-Resistant Depression
    Cullen, Kathryn
    Klimes-Dougan, Bonnie
    Amatya, Palistha
    Thai, Michelle
    Schreiner, Melinda Westlund
    Roback, Mark
    Albott, Sophia
    Ren, Yanan
    Eberly, Lynn
    Lim, Kelvin
    Mueller, Bryon
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S179 - S180
  • [28] Gene Expression and Molecular Pathways Associated With Rapid Antidepressant Response to Ketamine in Patients With Treatment Resistant Depression
    Bevilacqua, Laura
    Cathomas, Flurin
    Ramakrishnan, Aarthi
    Shen, Li
    Russo, Scott
    Murrough, James
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S16 - S16
  • [29] Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression
    Flurin Cathomas
    Laura Bevilacqua
    Aarthi Ramakrishnan
    Hope Kronman
    Sara Costi
    Molly Schneider
    Kenny L. Chan
    Long Li
    Eric J. Nestler
    Li Shen
    Dennis S. Charney
    Scott J. Russo
    James W. Murrough
    Translational Psychiatry, 12
  • [30] Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression
    Cathomas, Flurin
    Bevilacqua, Laura
    Ramakrishnan, Aarthi
    Kronman, Hope
    Costi, Sara
    Schneider, Molly
    Chan, Kenny L.
    Li, Long
    Nestler, Eric J.
    Shen, Li
    Charney, Dennis S.
    Russo, Scott J.
    Murrough, James W.
    TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)